An innovative therapeutic strategy to treat colon cancer is...

It has been identified how the combination of inhibitors of PP2A and WEE1 proteins induces the death of colon cancer cells, offering a new perspective in the treatment of this disease.

Read more

A clinical trial has demonstrated the efficacy of a shorter ...

Chagas disease 3 days ago

The new regimen has the same efficacy as the standard regimen, but only a quarter of the duration, which reduces the percentage of dropouts and side effects.

Read more

New mechanism discovered for the life-threatening arrhythmia...

The study demonstrates that a specific genetic mutation (C122Y) in the Kir2.1 potassium channel alters the function not only of Kir2.1 but also of the main cardiac sodium channel NaV1.5, thus establis...

Read more

Laura Soucek receives an ERC Advanced Grant to maximize the ...

Laura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies Group, has received a European Research Council (ERC) Adv...

Read more

Investigadores del IMIBIC diseñan un material inyectable qu...

virus HSV-1 3 days ago

Han comprobado que este biomaterial inyectable, diseñado mediante bioingeniería, puede sellar y rellenar perforaciones en córneas inflamadas y promover su regeneración, evitando así la necesidad ...

Read more

Desarrollo y caracterización de un nuevo fármaco para tumo...

KRASG12C (OFF), RAS, RMC-7977 3 days ago

Describen RMC-7977, un compuesto preclínico con un perfil inhibidor multiselectivo de RAS(ON), que fue diseñado para inhibir el espectro completo de mutaciones oncogénicas de RAS, incluyendo mutaci...

Read more

Un proyecto de la UE para establecer una terapia óptima par...

El proyecto tiene como objetivo establecer la terapia óptima para dos formas comunes de cáncer de la sangre: la leucemia mieloide aguda (AML) y la leucemia linfocítica crónica (CLL). Liderado por ...

Read more

Thermo Fisher Scientific Introduces Animal Origin-Free Formu...

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (CTS OpTmizer One SFM)*, a novel animal origin-free (AOF) formu...

Read more

Register your company

200€ anual fee for register your company profile in our directory

Pay the annual subscription fee

Access the complete management console

Write your own article

Intuitively publish your 10 articles/year for FREE


Recent Companies